THE CONTROL of vascular tone depends largely on the gradients of Na and Ca ions across the cell membrane (3, 23, 34) . The Na ϩ -K ϩ pump is the sole membrane protein responsible for Na ϩ efflux, extruding 3 Na ions and taking up 2 K ions against their concentration gradient, utilizing ATP hydrolysis to drive this process (39) . The Na ϩ -K ϩ pump maintains low intracellular Na ϩ concentrations ([Na ϩ ] i ) required for adequate removal of Ca 2ϩ from the cell via Na ϩ /Ca 2ϩ exchange. If agonist-induced increases in intracellular Ca 2ϩ concentrations ([Ca 2ϩ ] i ) via voltage-operated channels were not adequately counteracted by Na ϩ /Ca 2ϩ exchange, sustained vasoconstriction would ensue. Maintenance of a low [Na ϩ ] i is therefore essential in supporting normal vascular tone.
Insulin-like growth factor I (IGF-I) is a circulating hormone produced in the liver. It is also locally generated in vascular smooth muscle cells (VSMC), where it plays an important role in the regulation of cell proliferation (14, 22) . In addition, increasing evidence shows that IGF-I and insulin attenuate vasoconstrictive responses and increase blood flow, a process likely due to several components including stimulation of the Na ϩ -K ϩ pump in VSMC (6, 42) . Indeed, the vasodilator effects of IGF-I are more potent than those of insulin, and this correlates with the ability of these two hormones to stimulate the Na ϩ -K ϩ pump (38) . The elevated Na ϩ -K ϩ -pump activity could explain observations from singlecell analysis showing that insulin and IGF-I attenuate rises in [Ca 2ϩ ] i induced by vasoconstrictor agents (33) . Although various mechanisms to explain the attenuation of agonist-induced vasoconstriction by IGF-I and insulin have been proposed, the precise mode of action remains unclear.
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Cell culture. A7r5 cells were cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin G, and 100 µg/ml streptomycin in a humidified atmosphere of 5% CO 2 in air and used between passages 2 and 15. Cells were fed every other day. At 1 day postconfluence, cells were made quiescent by a 19-to 20-h incubation in DMEM containing 0.1% FBS.
Immunoblotting of Na ϩ -K ϩ pump. Quiescent A7r5 cells cultured in six-well plates were rinsed three times with ice-cold PBS and then harvested at 4°C in lysis buffer A containing 115 mM Tris · HCl (pH 6.8), 100 µM PMSF, 1 µM leupeptin, 1 µM pepstatin A, 4% SDS, 10 mM dithiothreitol (DTT), and 10% (vol/vol) glycerol. Protein samples (20 µg/ lane) were loaded onto 7.5% SDS-PAGE gels. Electrophoresis, protein transferring, and immunoblotting were performed as described previously (37) . Na ϩ -K ϩ -pump isoform-specific antibodies were diluted at 1:1,000 (McK1, 6H, SpET␤1, SpET␤2, and SpET␤3), 1:2,000 (HERED), or 1:500 (McB2).
Ouabain-sensitive 86 Rb ϩ uptake. Na ϩ -K ϩ -pump activity was measured as ouabain-sensitive 86 Rb ϩ uptake (37) . Quiescent A7r5 cells cultured in 24-well plates were rinsed once with 1 ml of HEPES-buffered saline solution (HBSS) containing (in mM) 140 NaCl, 2.4 MgSO 4 , 5 KCl, 1 CaCl 2 , and 20 Na-HEPES, pH 7.4. The cells were then incubated at 37°C for 30 min with 0.25 ml of HBSS in the presence or absence of 100 nM IGF-I. Where indicated, cells were preincubated for 20 min with the tyrosine kinase inhibitor genistein (5 µM), the PI3K inhibitors wortmannin (100 nM) or LY-294002 (25 µM), or the PKC inhibitor GF109203x (1 or 10 µM). The Na ϩ -K ϩ -2Cl Ϫ cotransporter inhibitor bumetanide (100 µM) or the Na ϩ /H ϩ exchanger inhibitor HOE-694 (5 µM) was added before the addition of IGF-I for 30 min. 86 Rb ϩ was then added in 50 µl of HBSS to a final concentration of 5 µCi/ml in the presence or absence of a final concentration of 1.6 mM ouabain, and uptake was allowed to proceed for 20 min. Na ϩ -K ϩ -pump activity was calculated as the difference between total 86 Rb ϩ uptake and ouabain-insensitive 86 Rb ϩ uptake and was linear over this 20-min period. After this period, the radioactive solution was aspirated and the cells were rinsed twice with 1 ml of ice-cold 0.9% NaCl. The cells were lysed with 1 ml of 0.05 N NaOH, and a 0.8-ml aliquot was counted using a liquid scintillation counter. The protein concentration of the lysate was determined using the Bradford method (4) .
Assay of PI3K activity associated with phosphotyrosine. To determine PI3K activity, cell extracts were prepared exactly the same way as for IRS-1 immunoprecipitation, and PI3K activity was measured on phosphotyrosine immunoprecipitates as described previously (46) . Briefly, the ability of PI3K associated with phosphotyrosine to convert phosphatidylinositol to phosphatidylinositol monophosphate (PIP) was detected by separation of these lipids by TLC. Detection and quantitation of [ 32 P]PIP on the TLC plates were done using a Molecular Dynamics PhosphorImager System (Sunnyvale, CA).
PKC-activity assay. Quiescent A7r5 cells cultured in 10-cm dishes were rinsed once with 10 ml of serum-free DMEM. The cells were then incubated at 37°C for 10 min with 10 ml of serum-free DMEM in the presence or absence of 100 nM IGF-I. Where indicated, cells were preincubated with the PKC inhibitor GF109203x (10 µM) for 20 min before IGF-I treatment. After treatment, cells were rinsed twice with ice-cold PBS and then harvested at 4°C in 1 ml of lysis buffer B containing 50 mM HEPES, pH 7.6, 150 mM NaCl, 10% (vol/vol) glycerol, 1% (vol/vol) Triton X-100, 30 mM Na 4 P 2 O 7 , 10 mM NaF, 1 mM Na 3 VO 4 , 100 nM okadaic acid, 1 mM EDTA, 1 mM PMSF, 1 mM benzamidine, and 1 mM DTT. Cells were homogenized by being passed five times through a 25-gauge syringe. Cell lysates were subjected to immnoprecipitation with anti-PKC-polyclonal antibody that was precoupled to a mixture of Protein A-and Protein G-Sepharose beads by incubating 2 µg of the antibody with 20 µl of the Protein A-/Protein G-Sepharose beads (100 mg/ml) at 4°C overnight. Antibody-coupled beads were washed twice with PBS and once with lysis buffer B. PKC-was immunoprecipitated by incubating the cell lysates (250 µg of total protein) with the anti-PKC-antibody-bead complex at 4°C for 3 h under constant rotation. The immunocomplex beads were sedimented and then washed four times with 1 ml of wash buffer [25 mM HEPES, pH 7.8, 1 M NaCl, 10% (vol/vol) glycerol, 1% (vol/vol) Triton X-100, 0.1% bovine serum albumin (BSA), 1 mM DTT, 1 mM PMSF, and 100 nM okadaic acid] and twice with 1 ml of kinase buffer (50 mM Tris · HCl, pH 7.5, 10 mM MgCl 2 , 1 mM DTT, and 100 nM okadaic acid). To measure PKC-activity, the beads were incubated under constant agitation at 30°C for 10 min with 30 µl of the kinase buffer supplemented with 5 µg of myelin basic protein and [␥- 32 http://ajpheart.physiology.org/ times for 10 min with 3 ml of 175 mM phosphoric acid and one time for 5 min with distilled water. Papers were air-dried and then subjected to liquid scintillation counting for measurement of 32 P incorporation into myelin basic protein.
Downregulation of PKC isoforms and immunoblotting. A7r5 cells cultured in six-well plates or 10-cm dishes were incubated with 1 µM PMA at 37°C for 24 h (5 h in DMEM-10% FBS, 19 h in DMEM-0.1% FBS). After treatment, cells were rinsed three times with ice-cold PBS and then harvested at 4°C in lysis buffer A as described in Immunoblotting of Na ϩ -K ϩ pump. Samples were homogenized using a 25-gauge syringe and then boiled for 5 min. Protein samples (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) µg/lane) were separated by electrophoresis on 7.5% SDS-PAGE gels and then transferred to polyvinylidene difluoride transfer membranes. Membranes were blocked for 1 h with 3% BSA in Tris-buffered saline containing 0.05% (vol/vol) Tween 20 and 0.05% (vol/vol) NP-40 and then incubated for 1 h with anti-PKC isoform-specific monoclonal antibodies at a 1:1,000 (PKC-␣, -␤, -␥, and -) or 1:750 (PKC-␦, -⑀, -, -, -, and -µ) dilution. After incubation with appropriate horseradish peroxidase-linked secondary antibody, specific binding was detected by means of the ECL immunoblotting detection system.
Statistical analysis. Values are given as means Ϯ SE. Data were analyzed by the Student's t-test or analysis of variance (ANOVA, Fisher Scientific) as indicated. P values Ͻ0.05 were considered significant.
RESULTS

Effect of IGF-I on Na
It has been reported that A7r5 VSMC express Na ϩ -K ϩ pump ␣ 1 -and ␣ 2 -subunits mRNA (44) . The present study confirmed the presence of ␣ 1 -subunit protein, which migrated at ϳ95 kDa, with the use of two different monoclonal antibodies, 6H and McK1. Skeletal muscle membranes were used as reference control (Fig. 1) . In carotid artery VSMC, a truncated ␣ 1 -isoform (65 kDa) is expressed (25) . In our study, a 65-kDa band was detectable by antibody McK1 in A7r5 cells but not by antibody 6H (data not shown). In contrast, we could not detect the ␣ 2 -subunit protein in these cells using two different antibodies specific for ␣ 2 , HERED, and McB2 (Fig. 1) . Of the ␤-subunit isoforms, ␤ 1 was readily visualized in A7r5 cells, and a protein of somewhat higher molecular mass was detected by anti-␤ 3 antibody. The ␤ 2 -isoform was not detected despite being abundant in (white) skeletal muscle (Fig. 1) .
The activity of the Na ϩ -K ϩ pump in A7r5 cells, measured as ouabain-sensitive 86 Rb ϩ (K ϩ ) uptake, constituted ϳ70% of total 86 Rb ϩ uptake ( Fig. 2A ). Incubation with 100 nM IGF-I for 30 min increased Na ϩ -K ϩ -pump activity by ϳ80% (Fig. 2A) . Ouabain-insensitive http://ajpheart.physiology.org/ 86 Rb ϩ uptake was not altered by IGF-I (data not shown). Acute incubation (10 min) with 100 nM IGF-I rapidly induced Na ϩ -K ϩ -pump stimulation with slightly higher levels apparent after 20 or 30 min of IGF-I incubation (Fig. 2B) . When several doses of IGF-I were tested, maximal stimulation was achieved with 10 and 100 nM IGF-I (Fig. 2C) .
Effect of tyrosine kinase inhibition on IGF-I-induced Na ϩ -K ϩ -pump stimulation. Tyrosine kinase activity has been established as an important component of IGF-I-triggered signaling cascades. Therefore, we first investigated the effect of the specific tyrosine kinase inhibitor genistein (1) on stimulation of the Na ϩ -K ϩ -pump by IGF-I. Figure 3 shows that genistein (5 µM) did not alter basal ouabain-sensitive 86 Rb ϩ uptake but completely prevented the stimulatory effect of IGF-I, suggesting that activation of tyrosine kinase(s) is required for IGF-I-mediated stimulation of Na ϩ -K ϩ -pump activity.
Involvement of PI3K in IGF-I-induced Na ϩ -K ϩ -pump stimulation. We then examined the role of PI3K in the stimulation of the Na ϩ -K ϩ pump by IGF-I. Inhibition of PI3K with wortmannin (100 nM) completely blocked IGF-I-induced Na ϩ -K ϩ -pump stimulation in these cells (Fig. 4A) . A second PI3K inhibitor, LY-294002 (25 µM), was also able to completely prevent Na ϩ -K ϩ -pump stimulation by IGF-I (Fig. 4A) . Neither of these inhibitors had any significant effect on basal Na ϩ -K ϩ -pump activity. To confirm that PI3K is indeed stimulated by IGF-I in these cells, PI3K activity associated with phosphotyrosine immunoprecipitates was measured using purified phosphatidylinositol as substrate. As shown in Fig.  4 , B and C, incubation with IGF-I for 5 min caused maximal activation of PI3K (ϳ12-fold). The activation was sustained to a significant extent in the continued presence of IGF-I for 50 min. In vitro incubation with the specific PI3K inhibitor wortmannin (100 nM) abolished the measured PI3K activity (Fig. 4, B and C) .
Involvement of atypical PKCs in Na ϩ -K ϩ -pump stimulation. It has been reported that certain PKCs are effectors of PI3K. As a preamble to determining the possible involvement of members of the PKC family in Fig. 3 . Effect of tyrosine kinase inhibitor genistein (Gen) on IGF-Iinduced stimulation of Na ϩ -K ϩ pump in A7r5 VSMC. Cells were preincubated with genistein (5 µM) for 20 min before incubation with 100 nM IGF-I for 30 min in continued presence of inhibitor. In basal group, ouabain-sensitive 86 Rb ϩ uptake over 20 min was 4.8 Ϯ 0.3 nmol/mg protein. This value was assigned a value of 100%, and other results were expressed relative to this value. All data are means Ϯ SE of 3 separate experiments performed in duplicate. * P Ͻ 0.05 compared with basal value (ANOVA). IGF-I action, we examined the complement of PKC isoforms expressed in A7r5 cells. Twelve PKC isoforms have been identified in mammalian cells, and these are classed in three groups: Ca 2ϩ -and diacylglycerol (DAG)-dependent ''conventional'' PKCs (␣-, ␤ I -, ␤ II -, and ␥-isoforms); Ca 2ϩ -independent and DAG-dependent ''novel'' PKCs (␦-, ⑀-, -, and -isoforms); and Ca 2ϩ -and DAGinsensitive ''atypical'' PKCs (-, -, -, and µ-isoforms) (15, 31) . We have demonstrated, in accordance with a previous report, that A7r5 cells express PKC-␣, -␥, -␦, -⑀, -, -, -, and -µ but not PKC-␤ or - (10) .
Twenty-four hour treatment with the phorbol ester PMA (1 µM) fully downregulated PKC-␣, -␥, and -␦ and partially downregulated PKC-⑀, whereas atypical PKC-, -, -, and -µ were unaffected (Fig. 5A) . The upper band in the PKC-immunoblot is most likely due to PKC-␣, which cross-reacts with the PKC-antibody (20) . This is supported by the fact that this band, like that of PKC-␣, was completely downregulated on PMA treatment.
Having shown the activation of PI3K by IGF-I and realizing that atypical PKC-has been shown to lie downstream of PI3K (30, 45) , we investigated whether IGF-I activates atypical PKC-in A7r5 cells. It should be noted here that the polyclonal antibody used to immunoprecipitate the kinase is marketed as being specific for PKC-but may also detect PKC-. Figure  5B shows that IGF-I activated PKC-activity ϳtwofold and that the activation was blocked by a high concentration (10 µM) of the PKC inhibitor GF109203x. We then http://ajpheart.physiology.org/ used two different approaches to investigate the role of atypical PKCs in the stimulation of Na ϩ -K ϩ -pump activity by IGF-I. Downregulation of PKCs by PMA did not inhibit IGF-I-induced Na ϩ -K ϩ -pump stimulation and had no effect on basal Na ϩ -K ϩ -pump activity (Fig. 5C ). This suggests that phorbol ester-sensitive PKC isoforms are not involved in mediating IGF-I action. However, the PKC inhibitor GF109203x (24) abolished Na ϩ -K ϩ -pump stimulation by IGF-I when used at 10 µM (inhibiting all PKCs) but not at 1 µM (inhibiting only conventional and novel PKCs) (Fig.  5D) . No significant effect of GF109203x on basal Na ϩ -K ϩ -pump activity was observed (Fig. 5D) . These results suggested that atypical PKC () participates in the signaling pathway mediating stimulation of the Na ϩ -K ϩ pump by IGF-I.
Role of [Na ϩ ] i in IGF-I-induced Na ϩ -K ϩ -pump stimulation. The contribution of entry of extracellular Na ϩ to IGF-I-induced Na ϩ -K ϩ -pump stimulation was evaluated by using specific inhibitors of the Na ϩ -K ϩ -2Cl Ϫ cotransporter and Na ϩ /H ϩ exchanger. These inhibitors [bumetanide (100 µM) and HOE-694 (5 µM), respectively] did not alter Na ϩ -K ϩ -pump stimulation by IGF-I and had no effect on basal Na ϩ -K ϩ -pump activity (Fig. 6 ). This suggests that the observed stimulation of the Na ϩ -K ϩ pump by IGF-I is not secondary to changes in [Na ϩ ] i .
DISCUSSION
Physiological role of the regulation of the Na ϩ -K ϩ pump by IGF-I in smooth muscle. IGF-I was first shown to stimulate Na ϩ -K ϩ -pump activity in VSMC in vitro in 1997 (42) , and it was hypothesized that locally produced IGF-I might have vasodilating activity in vivo. Very recently, IGF-I, but not insulin, was shown to increase blood flow via a vasodilating effect in the human forearm (32) . Consistent with these findings, we show here that IGF-I increased Na ϩ -K ϩ -pump activity in A7r5 VSMC derived from rat aorta. Unlike IGF-I, insulin did not stimulate the Na ϩ -K ϩ pump within Յ50 min (results not shown), although exposure to supraphysiological insulin concentrations for several hours can elevate pump content and, hence, net pump activity in these cells (44) . In addition, IGF-I is more potent than insulin in stimulating glucose transport in VSMC cells (41) , highlighting the importance of IGF-I in these cells. Locally produced IGF-I may act as an autocrine and/or paracrine factor by inducing vascular relaxation through activation of the Na ϩ -K ϩ -pump activity and consequently increasing the transmembrane Na ϩ gradient that drives Ca 2ϩ efflux via Na ϩ /Ca 2ϩ exchange. In this way, stimulation of the Na ϩ -K ϩ pump could lead to lowering vascular cytosolic Ca 2ϩ levels, thereby counteracting the effect of vasoconstriction stimuli. In addition, IGF-I promotes the production and release of nitric oxide from endothelium and VSMC (29, 48) . Both IGF-I and the Na ϩ -K ϩ pump have been implicated in diverse forms of hypertension. Indeed, several antihypertensive agents are thought to act, at least in part, by altering IGF-I expression (7). The ␣ 1 -Na ϩ -K ϩ -pump gene was recently shown to be a susceptibility hypertension gene in the Dahl salt-sensitive Harlan Sprague Dawley rat (12) , in part via its participation in renal Na ϩ handling. Moreover, pressure overload induces transcription of the ␣ 2 -Na ϩ -K ϩ -pump gene in rat and human aorta (35) , presumably in an attempt to counteract the insult under conditions in which ␣ 1 -pump activity is insufficient. Given these facts, it is attractive to pursue the possibility that physiologically IGF-I promotes Na ϩ -K ϩ -pump activity in vascular smooth muscle as an integral part of the maintenance of blood flow and counteraction of vasoconstriction. Ultimately, it is conceivable that the insulin resistance observed in type 2 diabetes and several forms of hypertension may also confer IGF-I resistance, compromising Na ϩ -K ϩ -pump stimulation by IGF-I.
Signals involved in the stimulation of the Na ϩ -K ϩ pump by IGF-I. Despite the importance of IGF-I in regulating ion fluxes in vascular smooth muscle, the mechanism of communication between the occupied IGF-I receptor and Na ϩ -K ϩ pump is not known. Therefore, in the present study we investigated the signaling pathways involved in the stimulation of Na ϩ -K ϩ -pump activity by IGF-I in VSMC. Signaling from the IGF-I receptor mirrors that for insulin in many ways, including activation of the receptor tyrosine kinase activity. We found that activation of tyrosine kinase(s) is necessary for the stimulation of the Na ϩ -K ϩ pump by IGF-I, based on its prevention by genistein. This compound also prevented the stimulation by epidermal growth factor and insulin of Na ϩ -K ϩ -pump activity in kidney tubular cells (9) . In contrast, the tyrosine kinase inhibitors lavendustin A (1 µM) and herbimycin (0.5 µM) were unable to attenuate IGF-I regulation of Na ϩ -K ϩ -pump activity in primary cultures of VSMC (42) . A plausible reason for this unexpected discrepancy is the http://ajpheart.physiology.org/ differential selectivity of these inhibitors for individual tyrosine kinases (40) .
In a similar fashion to insulin action, it has been established that activation of PI3Ks is essential in mediating several effects of IGF-I (16). Indeed, activation of N-and L-type Ca 2ϩ channels in cerebellar granule neurons by IGF-I requires PI3K activity (2) . We recently reported that insulin stimulates Na ϩ -K ϩ -pump activity in 3T3-L1 fibroblasts by a pathway involving PI3K (43) . In the present study we found that IGF-I stimulated and maintained an elevated PI3K activity for Յ50 min in A7r5 VSMC. PI3K stimulation was inhibited by wortmannin, and both wortmannin and LY-294002 also inhibited Na ϩ -K ϩ -pump stimulation. These results suggest an essential role for PI3K in IGF-I-mediated stimulation of the Na ϩ -K ϩ pump in VSMC.
The PKC family members have been proposed as both mediators and inhibitors of insulin action (5) . Recent studies have strongly implicated the atypical isoforms of the PKC family as substrates of PI3K and mediators of insulin action (8) . Most recently, promotion of macrophage differentiation by IGF-I was found to involve activation of PI3K and PKC- (21) . Several studies in cultured cells have shown that reduced Na ϩ -K ϩ -pump activity is a common consequence of hyperglycemia as observed in individuals with type 2 diabetes (47). Hyperglycemia increases vascular tone by increasing DAG levels and, therefore, DAG-sensitive PKC activity (17) . Thus we designed our next set of experiments to examine the role of both DAG-sensitive and atypical PKC isoforms in IGF-I-mediated stimulation of the Na ϩ -K ϩ pump in VSMC.
The results presented in this study show that atypical, but not conventional or novel, isoforms of the PKC family are indeed required for IGF-I-mediated stimulation of the Na ϩ -K ϩ pump in VSMC. To establish this fact, we first exploited the fact that DAG-sensitive PKC isoforms can be downregulated by long-term phorbol ester treatment. We confirmed that this method was effective by immunoblotting with isoform-specific antibodies. When Na ϩ -K ϩ -pump activity was assessed in cells no longer expressing DAG-sensitive PKC isoforms, there was no change in basal or IGF-I-stimulated activity. However, the ability to discriminate between atypical and other PKC isoforms with the inhibitor GF109203x allowed us to study the role of these PKC isoforms in IGF-I action (24) . Interestingly, we found that inhibition of atypical isoforms with 10 µM GF109203x prevented IGF-I action. Moreover, we showed that IGF-I activated atypical PKC-and that this activation was prevented by 10 µM GF109203x. Previous studies (42) using staurosporine to inhibit PKC failed to show a role for PKC in IGF-I-stimulated VSMC Na ϩ -K ϩ -pump activity. However, only 10 nM staurosporine was used in that study, and it is appreciated that much higher concentrations of this rather nonspecific inhibitor are needed to inhibit the atypical PKC- (IC 50 1.3 µM) .
Stimulation of Na ϩ -K ϩ pump in VSMC does not require prior Na ϩ entry. We have shown recently (43) that insulin-stimulated increases in Na ϩ -K ϩ -pump activity in 3T3-L1 fibroblasts required antecedent stimulation of the Na ϩ -K ϩ -2Cl Ϫ cotransporter. The ensuing increased [Na ϩ ] i was sufficient to increase Na ϩ -K ϩ -pump activity. In contrast, here we show that the stimulatory effect of IGF-I on the Na ϩ -K ϩ pump in A7r5 cells was not secondary to the changes in Na ϩ entry via the Na ϩ -K ϩ -2Cl Ϫ cotransporter or Na ϩ /H ϩ exchanger. The mechanism of Na ϩ -K ϩ -pump activation in this case may be via either direct activation or translocation of ␣-subunits to the plasma membrane. In preliminary experiments using HEK cells overexpressing hemagglutinin (HA)-tagged ␣ 1 -Na ϩ -K ϩ -pump isoforms (the same isoform found in A7r5 cells) we have observed increased HA-tagged ␣ 1 -subunit exposure at the cell surface in response to IGF-I. Whereas these findings are indicative of a potential mechanism, the relevance of this system to smooth muscle cells remains to be established.
In summary, IGF-I provokes increases in VSMC Na ϩ -K ϩ -pump activity by a pathway involving tyrosine kinase(s), PI3K, and atypical PKC (possibly the -isoform). Defects in Na ϩ -K ϩ -pump activity have been associated with primary essential hypertension as well as hypertension related to diabetes. We hypothesize that in insulin resistant states there may be defects in the pathway of stimulation of the Na ϩ -K ϩ pump by IGF-I, contributing to the development of hypertension.
